Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility.
Identifikátory výsledku
Kód výsledku v IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F14%3A00074873" target="_blank" >RIV/00216224:14110/14:00074873 - isvavai.cz</a>
Nalezeny alternativní kódy
RIV/65269705:_____/14:00061483
Výsledek na webu
<a href="http://dx.doi.org/10.1155/2014/575978" target="_blank" >http://dx.doi.org/10.1155/2014/575978</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1155/2014/575978" target="_blank" >10.1155/2014/575978</a>
Alternativní jazyky
Jazyk výsledku
angličtina
Název v původním jazyce
Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility.
Popis výsledku v původním jazyce
Aims. In this study we report our results with storage of cryopreserved semen intended for preservation and subsequent infertility treatment in men with testicular cancer during the last 18 years. Methods. Cryopreserved semen of 523 men with testicular cancer was collected between October 1995 and the end of December 2012. Semen of 34 men (6.5%) was used for fertilization of their partners. They underwent 57 treatment cycles with cryopreserved, fresh, and/or donor sperm. Results. A total of 557 men havedecided to freeze their semen before cancer treatment. Azoospermia was diagnosed in 34 men (6.1%), and semen was cryopreserved in 532 patients. Seminoma was diagnosed in 283 men (54.1%) and nonseminomatous germ cell tumors in 240 men (45.9%). 34 patients who returned for infertility treatment underwent 46 treatment cycles with cryopreserved sperm. Totally 16 pregnancies were achieved, that is, 34.8% pregnancy rate. Conclusion.
Název v anglickém jazyce
Sperm cryopreservation before testicular cancer treatment and its subsequent utilization for the treatment of infertility.
Popis výsledku anglicky
Aims. In this study we report our results with storage of cryopreserved semen intended for preservation and subsequent infertility treatment in men with testicular cancer during the last 18 years. Methods. Cryopreserved semen of 523 men with testicular cancer was collected between October 1995 and the end of December 2012. Semen of 34 men (6.5%) was used for fertilization of their partners. They underwent 57 treatment cycles with cryopreserved, fresh, and/or donor sperm. Results. A total of 557 men havedecided to freeze their semen before cancer treatment. Azoospermia was diagnosed in 34 men (6.1%), and semen was cryopreserved in 532 patients. Seminoma was diagnosed in 283 men (54.1%) and nonseminomatous germ cell tumors in 240 men (45.9%). 34 patients who returned for infertility treatment underwent 46 treatment cycles with cryopreserved sperm. Totally 16 pregnancies were achieved, that is, 34.8% pregnancy rate. Conclusion.
Klasifikace
Druh
J<sub>x</sub> - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
CEP obor
FK - Gynekologie a porodnictví
OECD FORD obor
—
Návaznosti výsledku
Projekt
—
Návaznosti
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Ostatní
Rok uplatnění
2014
Kód důvěrnosti údajů
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Údaje specifické pro druh výsledku
Název periodika
The Scientific World Journal
ISSN
1537-744X
e-ISSN
—
Svazek periodika
2014
Číslo periodika v rámci svazku
"575978"
Stát vydavatele periodika
US - Spojené státy americké
Počet stran výsledku
5
Strana od-do
1-5
Kód UT WoS článku
000330652400001
EID výsledku v databázi Scopus
—